The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Clinical Tral of Jinerlun in the Treatment of Cerbral Infarction
Author(s): 
Pages: 77-78
Year: Issue:  10
Journal: CHINA JOURNAL OF MODERN MEDICINE

Keyword:  金尔伦脑梗塞;
Abstract: 目的:观察金尔伦治疗脑梗塞的疗效及安全性.方法:选择经头颅CT扫描确诊的脑梗塞93例,随机分为治疗组48例,给予金尔伦0.04mg/kg*d,川芎嗪80~120mg/d静滴,对照组45例单用川芎嗪80~120mg/d静滴,均14d为一疗程.结果:治疗组疗效明显高于对照组(P<0.01);治疗组病程在24h内用药的显效率为(92%),明显高于病程超过24h内用药的显效率为92%,明显高于病程超过24h的显效率60.9%(P<0.05),仅发现1例轻度血压升高,1例出现恶心、呕吐.结论:金尔伦治疗脑梗塞疗效显著而安全,且用药时间越早越好.
Related Articles
loading...